In this version of The Post Roll, Thomas George and Scott Willis assessment the flurry of earnings releases within the hashish sector.
Aphria – Winning in Cannabis 2.0
Aphria had a really stable earnings launch, we study the two methods traders can win proudly owning the identify and why a hedged (lengthy/brief) technique is one of the best threat/reward.
Organigram – Is there a Cash Crunch?
The firm was as soon as a pot shares darling, nonetheless the newest earnings weren’t a factor of magnificence. Is the corporate dealing with a money crunch?
Aurora – The Pain Trade Continues
Aurora has been a catastrophe for investor, after a 12 for 1 inventory reverse cut up does this mark the tip of the ‘pain trade’?
Fire & Flower
Is there More Dilution on the Way? Scott outlines the runway for the inventory.
Valens – The Preferred Cannabis Oil Play
Scott Willis explains why Valens is effectively positioned relative to Medipharm Labs.
The opinions offered on this article are these of the writer and don’t represent funding recommendation. Readers ought to assume that the writer and/or workers of Grizzle maintain positions within the firm or firms talked about within the article. For extra data, please see our Content Disclaimer.